DOI: 10.1200/jco.2016.70.1524 link

PMID: 28328302

OpenAlex ID: W2602907503

Category: Oncology

Title: Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study

Authors: Joshua Bauml, Xinxin Shu, Jonathan D. Cheng, Robert I. Haddad, Lori J. Wirth, Ammar Sukari, Hyunseok Kang, Michael K. Gibson, Erminia Massarelli,... (18 authors, truncated)

Publishing date: 10-May-2017

YCR = 2017  / 528 /  14.72 

Version 1.00            Year       /   Citations  /   Relative

Metric Value Date of Calculation

Citations count

528

30-May-2024

Relative

14.72

04-Aug-2024

Article Expected CPY (Citations per Year): 5.12 Expected CPY Help

Article Actual CPY: 75.43 Actual CPY Help

Article Co-Citation FCR (Field Citation Rate): 6.89 FCR Help

Article Co-Citation Network Size: 39540 Co-Citation Network Size Help

Article Topics: Cancer Immunotherapy, Epidemiology and Treatment of Head and Neck Cancer, Advancements in Lung Cancer Research Topics help

Article Keywords: Cetuximab, Treatment Guidelines Keywords Help

Journal: Journal of clinical oncology

Journal IF-ycr: 1.644 Journal IF-ycr Help

Journal short code: NA

Journal ISSN: 0732-183X

Journal OA-ID: 15137598

Help

Expected CPY Help: Predicted citations per year for this article, derived from its Field Citation Rate (FCR) using a benchmark regression of NIH-funded papers. Values above actual CPY indicate under-performance; below indicate over-performance. Used as the denominator of the Relative Citation Ratio.

Back to top

Actual CPY Help: Average yearly citations the article has received from publication through the current year, adjusted for partial years. Used as the numerator of the Relative Citation Ratio.

Back to top

FCR Help: Mean journal citation rate for all papers in the article's co-citation network. For each network paper we substitute its journal’s impact factor (calculated from open data) as a proxy for citations per year, then average these values. This captures the citation intensity of the article's immediate research field and forms the basis for computing expected CPY.

Back to top

Co-Citation Network Size Help: Number of unique papers co-cited with this article by its citing papers; larger networks yield more stable field estimates when calculating FCR and expected CPY.

Back to top

Topics Help: OpenAlex assigns topics to each paper with an AI model that considers the title, abstract, journal, and citation links. Tags are chosen from about 4,500 research areas, and the highest-confidence tag becomes the paper's primary topic. Every topic sits in a hierarchy of domain, field, and subfield, so you can see exactly where the work fits in the wider map of science.

Back to top

Keywords Help: Keywords are generated automatically from the paper's assigned topics. The OpenAlex system selects candidate terms, then keeps up to five that match closely with the title or abstract. These keywords highlight specific concepts or methods and give a quick complement to the broader topic tags.

Back to top

Journal IF-ycr Help: Journal IF-ycr is a two-year impact factor recalculated from OpenAlex's open citation data. For a given journal and year Y, we:

  1. Count citations made in year Y by any paper to items that the journal published in years Y-1 and Y-2 (excluding the current year).
  2. Divide that citation count by the number of articles the journal published in those same two years.
This yields an impact factor analogue built entirely from open data, updated annually and used in the YCR workflow.

Back to top